European shares gain on earnings boost; Novo Nordisk slips

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

European shares gain on earnings boost; Novo Nordisk slips

- European shares opened higher on Wednesday, as a slew of upbeat corporate earnings lifted sentiment, although gains were capped after heavyweight Novo Nordisk (NYSE:Novo Nordisk dropped 6.6% after the obesity drugmaker posted quarterly operating profit below expectations and also cut its annual profit outlook.

Among other notable moves, car parts maker Continental jumped 5% after it trounced expectations for second-quarter results.Beiersdorf slipped nearly 4% despite the Nivea maker reporting a 7.1% organic sales growth for the first half of the year.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 450. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
La source: NBCLA - 🏆 319. / 59 Lire la suite »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Lilly, Novo Nordisk Battle for Weight-loss Market Lands At the Pharmacy ShelfAs Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is...
La source: Medscape - 🏆 386. / 55 Lire la suite »